A hormone therapy commonly used to prevent preterm births probably isn’t effective, a new study reports. Doctors have been prescribing vaginal progesterone treatments to help at-risk pregnant women delay delivery for as long as possible, researchers said. But a new study involving more than 1,600 pregnant women with a history of early delivery revealed that… read on > read on >
Poor sleep may be linked to glaucoma, a leading cause of blindness, new research suggests. The study drew on a database of more than 400,000 people to explore links between sleep and vision loss. Glaucoma is marked by progressive loss of light-sensitive cells in the eye and optic nerve damage. Left untreated, it can cause… read on > read on >
New research reveals that the brain is much more flexible than once thought and can change rapidly during treatment for major depression. People receiving inpatient treatment for major depression had increased brain connectivity after just six weeks, German researchers report. They compared brain connectivity — various brain regions acting together in generating thought, emotion and… read on > read on >
For women, the key to getting ahead at work could be getting more shut-eye. Quality sleep boosted women’s moods, which then made them more intent on work achievements, a new study found. Researchers from Washington State University and University of Minnesota-Duluth surveyed 135 U.S. workers (men and women) twice a day for over two weeks… read on > read on >
Most pregnant women are told it’s safe to have one cup of coffee a day because it won’t trigger miscarriages or preterm deliveries, but new research suggests a surprising risk: Moms-to-be who consume caffeine, even in small amounts, may have shorter kids. “The main takeaway is that even low exposure to caffeine during pregnancy was… read on > read on >
A new analysis illustrates the impact of the U.S. Supreme Court’s decision to overturn Roe v. Wade: In numerous states, women now have no choice but to travel long distances to get an abortion. One-third of American women of reproductive age must now drive excessive distances, the researchers reported. Twice as many women must now… read on > read on >
A new malaria antibody treatment may keep more people free of the sometimes deadly disease for up to six months in regions where infection rates are high. Instead of requiring the immune system to make enough antibodies, this experimental drug provides those who receive it with a large amount of lab-made antibodies. It requires an… read on > read on >
Doctors could soon have access to a new weapon in the ongoing battle against antibiotic-resistant bacteria. An experimental combination antibiotic appears to offer a new option for doctors treating stubborn drug-resistant urinary tract infections (UTIs), according to new clinical trial results. The new combo of cefepime and enmetazobactam outperformed an established antibiotic drug regimen in… read on > read on >
Experts are once again advising doctors and women against using menopausal hormone therapy to ward off chronic diseases — 20 years after a landmark trial dashed those hopes. In updated recommendations, the U.S. Preventive Services Task Force (USPSTF) is reiterating its past advice on menopausal hormone therapy: It should not be prescribed as a way… read on > read on >
TUESDAY, Nov. 1, 2022 (American Heart Association News) — A third dose of the Moderna or Pfizer COVID-19 vaccine poses no more risk of heart inflammation than a second dose, a large study suggests. The findings could help allay concerns about risk going up with each additional dose. Cases were rare. Most appeared within seven… read on > read on >
